Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Provided By GlobeNewswire
Last update: Nov 5, 2024
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will report third quarter 2024 financial and operating results after market close on Tuesday, November 12, 2024. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET.
Read more at globenewswire.com
